This is the guy you want in your court! Joe's oncologist at M.D. Anderson is the world renowned Dr. James Abbruzzese, who specializes in pancreatic cancer.
Dr. Abbruzzese is the Chairman of the Department of Gastrointestinal Medical Oncology at the University of Texas M. D. Anderson Cancer Center in Houston, Texas. Dr. Abbruzzese is one of the world's foremost leaders in the clinical study and treatment of pancreatic cancer.
Dr. Abbruzzese research is focused on the development of novel therapeutic agents for pancreatic and other gastrointestinal cancers. He is principal investigator of a phase I drug development grant from the National Cancer Institute and another grant to develop techniques to assess the impact of novel targeted therapeutic agents in cancer patients.
Dr. Abbruzzese has been published in the Journal of Clinical Oncology and is the author of over 150 articles and book chapters and is Editor-in-Chief of the International Journal of Pancreatology. He serves on the editorial board of a number of prestigious journals, including the Journal of Clinical Oncology and Clinical Cancer Research, and also serves on the Scientific Advisory Board of the Lustgarten Foundation for Pancreatic Cancer Research.
He has also been named a National Thought Leader in the area of pancreatic cancer by BioMedical Insights, Inc. Dr. Abbruzzese is a Fellow of the Royal Society of Medicine and a Fellow of the American College of Physicians.
Dr. Abbruzzese is the Chairman of the Department of Gastrointestinal Medical Oncology at the University of Texas M. D. Anderson Cancer Center in Houston, Texas. Dr. Abbruzzese is one of the world's foremost leaders in the clinical study and treatment of pancreatic cancer.
Dr. Abbruzzese research is focused on the development of novel therapeutic agents for pancreatic and other gastrointestinal cancers. He is principal investigator of a phase I drug development grant from the National Cancer Institute and another grant to develop techniques to assess the impact of novel targeted therapeutic agents in cancer patients.
Dr. Abbruzzese has been published in the Journal of Clinical Oncology and is the author of over 150 articles and book chapters and is Editor-in-Chief of the International Journal of Pancreatology. He serves on the editorial board of a number of prestigious journals, including the Journal of Clinical Oncology and Clinical Cancer Research, and also serves on the Scientific Advisory Board of the Lustgarten Foundation for Pancreatic Cancer Research.
He has also been named a National Thought Leader in the area of pancreatic cancer by BioMedical Insights, Inc. Dr. Abbruzzese is a Fellow of the Royal Society of Medicine and a Fellow of the American College of Physicians.
No comments:
Post a Comment